News Articles Tagged: HepG2 Cells

Unlocking Anticancer Potential: 2,2'-Bipyridine Derivatives and HepG2 Cells

Explore the emerging research on 2,2'-Bipyridine derivatives as potential anticancer agents, focusing on their impact on HepG2 liver cancer cells and the underlying mechanisms.

Anticancer Potential of 2,2'-Bipyridine Derivatives: Targeting HepG2 Cells

An in-depth look at how 2,2'-bipyridine derivatives are being investigated for their anticancer efficacy against hepatocellular carcinoma (HepG2) cells, focusing on apoptosis and ROS mechanisms.